Related Experiment Video
Updated: May 31, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency
Sian A Thompson1, Jacqui Calvin, Sarah Hogg
1Addenbrooke's Hospital, Department of Neurology, Hills Road, Cambridge, CB2 0QQ, UK.
Abstract:
α-Methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.
Related Concept Videos
Hepatic Encephalopathy
Inborn Errors of Metabolism
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Rocky Mountain Spotted Fever
